CELL THERAPY USING MIDBRAIN-TYPE NEURAL STEM CELLS TREATED WITH VITAMIN C

摘要

The present invention relates to a cell therapeutic agent including ventral midbrain-type neural stem cells (VM-NSCs) obtained by treating vitamin C during cell expansion to prevent or treat a neurological disease. Since the vitamin C treatment during NSC expansion prevents the loss of therapeutic function-related NSC characteristics, such as expression of midbrain-specific factors, in the cell expansion, a safe, simple and effective method for mass-producing a cell therapeutic agent with excellent therapeutic functions is provided.